The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan

BACKGROUND: Since June 2019, cancer genomic profiling (CGP) tests have been reimbursed by the National Health Insurance system in Japan, with restrictions for government-designated hospitals with a molecular tumor board composed of multidisciplinary specialists, known as an expert panel (EP). The st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunami, Kuniko, Naito, Yoichi, Aimono, Eriko, Amano, Toraji, Ennishi, Daisuke, Kage, Hidenori, Kanai, Masashi, Komine, Keigo, Koyama, Takafumi, Maeda, Takahiro, Morita, Sachi, Sakai, Daisuke, Kohsaka, Shinji, Tsuchihara, Katsuya, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895780/
https://www.ncbi.nlm.nih.gov/pubmed/33385275
http://dx.doi.org/10.1007/s10147-020-01844-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895780/
https://www.ncbi.nlm.nih.gov/pubmed/33385275
http://dx.doi.org/10.1007/s10147-020-01844-1

Ejemplares similares